Guest guest Posted September 21, 2005 Report Share Posted September 21, 2005 No, I did not make that title up. This one is for Agent Bleu. J Clin Invest. 2005 Mar;115(3):591-3. Comment on: J Clin Invest. 2005 Mar;115(3):642-52. Licking latency with licorice. Cohen JI. Medical Virology Section, Laboratory of Clinical Infectious Diseases, NIH, Bethesda, land 20892, USA. jcohen@... Numerous viruses cause latent infections in humans, and reactivation often results in pain and suffering. While vaccines for several of these viruses are available or currently being studied in clinical trials, and antiviral therapies have been successful in preventing or treating active infection, therapy to eradicate latent infection has lagged behind. A new study reported in this issue of the JCI shows that treatment of cells latently infected with Kaposi sarcoma- associated herpesvirus (KSHV) with glycyrrhizic acid, a component of licorice, reduces synthesis of a viral latency protein and induces apoptosis of infected cells. This finding suggests a novel way to interrupt latency. Publication Types: Comment PMID: 15765143 [PubMed - indexed for MEDLINE] Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.